122 related articles for article (PubMed ID: 20358444)
1. Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies.
Meng Z; Quan H; Fan L; Kringle R; Sun G
J Biopharm Stat; 2010 May; 20(3):665-82. PubMed ID: 20358444
[TBL] [Abstract][Full Text] [Related]
2. Sample size calculation for thorough QT/QTc study considering various factors related to multiple time points.
Meng Z; Kringle R; Chen X; Zhao PL
J Biopharm Stat; 2010 May; 20(3):563-77. PubMed ID: 20358436
[TBL] [Abstract][Full Text] [Related]
3. Statistical characterization of QT prolongation.
Schall R; Ring A
J Biopharm Stat; 2010 May; 20(3):543-62. PubMed ID: 20358435
[TBL] [Abstract][Full Text] [Related]
4. Sample size and power estimation in "thorough" QT/QTc studies with parallel group design.
Hosmane B; Locke C; Chiu YL
J Biopharm Stat; 2010 May; 20(3):578-86. PubMed ID: 20358437
[TBL] [Abstract][Full Text] [Related]
5. A nonparametric approach to QT interval correction for heart rate.
Wang D; Cheung YB; Arezina R; Taubel J; Camm AJ
J Biopharm Stat; 2010 May; 20(3):508-22. PubMed ID: 20358433
[TBL] [Abstract][Full Text] [Related]
6. Statistical characteristics of moxifloxacin-induced QTc effect.
Yan LK; Zhang J; Ng MJ; Dang Q
J Biopharm Stat; 2010 May; 20(3):497-507. PubMed ID: 20358432
[TBL] [Abstract][Full Text] [Related]
7. An efficient and robust analysis of covariance model for baseline adjustment in parallel-group thorough QT/QTc studies.
Lu K
Stat Med; 2013 Jun; 32(14):2406-18. PubMed ID: 22996035
[TBL] [Abstract][Full Text] [Related]
8. Multiple comparisons of repeated measured response: issues of assessment of prolongation of QT interval in thorough QT trials.
Tsong Y; Zhong J
J Biopharm Stat; 2010 May; 20(3):604-14. PubMed ID: 20358439
[TBL] [Abstract][Full Text] [Related]
9. Impact of baseline ECG collection on the planning, analysis and interpretation of 'thorough' QT trials.
Sethuraman V; Sun Q
Pharm Stat; 2009; 8(2):113-24. PubMed ID: 18481273
[TBL] [Abstract][Full Text] [Related]
10. Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables.
Cheng B; Chow SC; Burt D; Cosmatos D
J Biopharm Stat; 2008; 18(3):494-501. PubMed ID: 18470758
[TBL] [Abstract][Full Text] [Related]
11. A comparison of several methods for analyzing data from thorough QT studies.
Tian H; Qiao W; Natarajan J
J Biopharm Stat; 2010 May; 20(3):632-40. PubMed ID: 20358441
[TBL] [Abstract][Full Text] [Related]
12. Multiple comparisons of repeatedly measured response: issues of validation testing in thorough QT/QTc clinical trials.
Tsong Y; Yan LK; Zhong J; Nie L; Zhang J
J Biopharm Stat; 2010 May; 20(3):654-64. PubMed ID: 20358443
[TBL] [Abstract][Full Text] [Related]
13. Exposure-response modeling approach for assessing QT effect in "thorough" QT/QTc studies.
Hosmane B; Locke C; Chiu YL
J Biopharm Stat; 2010 May; 20(3):615-31. PubMed ID: 20358440
[TBL] [Abstract][Full Text] [Related]
14. Statistical consideration in testing for assay sensitivity in a "thorough" QT study.
Sethuraman V; Wu S; Wang J
J Biopharm Stat; 2010 May; 20(3):641-53. PubMed ID: 20358442
[TBL] [Abstract][Full Text] [Related]
15. Comparison of six commonly used QT correction models and their parameter estimation methods.
Wang D; Taubel J; Arezina R
J Biopharm Stat; 2012; 22(6):1148-61. PubMed ID: 23075014
[TBL] [Abstract][Full Text] [Related]
16. Effect of baseline measurement on the change from baseline in QTc intervals.
Tian H; Natarajan J
J Biopharm Stat; 2008; 18(3):542-52. PubMed ID: 18470762
[TBL] [Abstract][Full Text] [Related]
17. QT analysis: a complex answer to a 'simple' problem.
Li L; Desai M; Desta Z; Flockhart D
Stat Med; 2004 Sep; 23(17):2625-43. PubMed ID: 15316947
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian measurement error approach to QT interval correction and prolongation.
Chen J; Zhao X
J Biopharm Stat; 2010 May; 20(3):523-42. PubMed ID: 20358434
[TBL] [Abstract][Full Text] [Related]
19. Comparison of statistical models adjusting for baseline in the analysis of parallel-group thorough QT/QTc studies.
Sun GG; Quan H; Kringle R; Meng Z
J Biopharm Stat; 2012; 22(3):438-62. PubMed ID: 22416834
[TBL] [Abstract][Full Text] [Related]
20. Is a thorough QTc study necessary? The role of modeling and simulation in evaluating the QTc prolongation potential of drugs.
Rohatagi S; Carrothers TJ; Kuwabara-Wagg J; Khariton T
J Clin Pharmacol; 2009 Nov; 49(11):1284-96. PubMed ID: 19734373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
